Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.1275
-0.0036 (-2.75%)
Oct 19, 2026, 1:21 PM EDT - Market open
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $2.57 million as of October 19, 2026. It is the 47,247th most valuable company in the world and the 6,329th biggest in the United States. Its market cap has decreased by 88.21% in one year.
Market Cap
2.57M
Enterprise Value
13.30M
1-Year Change
-88.21%
Global Rank
Country Rank
#6,329 United States
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $2.57M, a decrease of -97.52%. That is a compound annual growth rate of -46.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 2.57M | -85.94% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aethlon Medical | 3.64M |
| 20/20 Biolabs | 3.33M |
| Bluejay Diagnostics | 3.33M |
| INVO Fertility | 2.66M |
| WORK Medical Technology Group LTD | 2.64M |
| VolitionRx | 2.56M |
| Adagio Medical Holdings | 2.20M |
| Beyond Air | 2.13M |